Kei Miyakawa

National Institute of Infectious Diseases

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (5)

Hisataka Kobayashi

Chief Scientist/ Senoir Investigator

National Cancer Institute

UNITED STATES

Junso Fujita

Specially Appointed Assistant Professor

Osaka University

Hideaki Nakajima

Yokohama City University Graduate School of Medicine

Kotaro Shirakawa

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

Akihide Ryo

Yokohama National University

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kei Miyakawa

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (5)

Hisataka Kobayashi

Junso Fujita

Hideaki Nakajima

Kotaro Shirakawa

Akihide Ryo

Make your next move.

Kei Miyakawa

Research Interests

Explore related searches

Contact this professor

Articles (19)

Rapid quantitative detection system for measles virus-neutralizing antibodies using HiBiT-tagged virus-like particles

Replication efficiency of SARS-CoV-2 Omicron subvariants BA.2.75, BA.5, and XBB.1 in human mini-gut organoids

Integrated tandem affinity protein purification using the polyhistidine plus extra 4 amino acids (HiP4) tag system

Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare Workers

Photoimmunotechnology as a powerful biological tool for molecular-based elimination of target cells and microbes, including bacteria, fungi and viruses

Development of a contacting transwell co-culture system for the &lt;i&gt;in vitro&lt;/i&gt; propagation of primary central nervous system lymphoma

Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology

Crosstalk between the innate immune system and selective autophagy in hepatitis B virus infection

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera

A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron

MAL Inhibits the Production of HIV-1 Particles by Sequestering Gag to Intracellular Endosomal Compartments

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay

Antimicrobial strategy for targeted elimination of different microbes, including bacterial, fungal and viral pathogens

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection.

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.

Collaborators (5)

Hisataka Kobayashi

Junso Fujita

Hideaki Nakajima

Kotaro Shirakawa

Akihide Ryo

Make your next move.

Development of a contacting transwell co-culture system for the <i>in vitro</i> propagation of primary central nervous system lymphoma